Influencing factors for digital subtraction angiography and cone-beam computed tomography guided bead chemoembolization in resistant liver cancer

Table 1 Univariate analysis of factors influencing drug-eluting bead-transcatheter arterial chemoembolization efficacy in patients with transcatheter arterial chemoembolization failure/refractoriness and hepatocellular carcinoma, n (%)

Indicator	Favorable outcome group (n = 64)	Poor outcome group (n = 32)	χ2	P value
Sex			2.859	0.091
Male	52 (81.25)	21 (65.63)
Female	12 (18.75)	11 (34.38)
Age			0.208	0.649
< 60	43 (67.19)	20 (62.50)
≥ 60	21 (32.81)	12 (37.50)
BMI (kg/m2)			0.433	0.511
< 21	18 (28.13)	7 (21.88)
≥ 21	46 (71.88)	25 (78.13)
Lesion diameter (cm)			7.862	0.005
< 5	45 (70.31)	13 (40.63)
≥ 5	19 (29.69)	19 (59.38)
Etiology			2.041	0.360
Hepatitis B	46 (71.88)	27 (84.38)
Hepatitis C	13 (20.31)	3 (9.38)
Other disease	5 (7.81)	2 (6.25)
Multiple lesions			8.116	0.004
Yes	17 (26.56)	18 (56.25)
No	47 (73.44)	14 (43.75)
Hypertension			0.618	0.432
Yes	21 (32.81)	8 (25.00)
No	43 (67.19)	24 (75.00)
Portal vein invasion			0.025	0.874
Yes	19 (29.69)	9 (28.13)
No	45 (70.31)	23 (71.88)
Hepatocirrhosis			1.325	0.250
Yes	19 (29.69)	6 (18.75)
No	45 (70.31)	26 (81.25)
Child-Pugh classification			16.200	< 0.001
A	49 (76.56)	11 (34.37)
B	15 (23.44)	21 (65.63)
Preoperative AFP levels (ng/mL)			7.200	0.007
< 400	46 (71.88)	14 (43.75)
≥ 400	18 (28.13)	18 (56.25)

BMI: Body mass index; AFP: Alpha-fetoprotein.